Lumenis Ltd., an Israeli medtech company that makes lasers used in eye surgery, urology and cosmetic medical procedures, filed today for an initial public offering worth $115 million.
Yokneam, Israel-based Lumenis said it plans to trade on the NASDAQ stock exchange under the "LMNS" symbol.
Goldman Sachs, Credit Suisse, Jefferies and Wells Fargo Securities are the joint bookrunners on the offering, according to a regulatory filing.
Lumenis is fresh off of a pair of regulatory wins in the U.S. and Japan for its Array LaserLink, a pattern scanning device for multi-spot laser photocoagulation during retinal surgery.
No per-share price has yet been assigned to the IPO.